Impaired frequencies and function of platelets and tissue remodeling in chronic Chagas disease

Claudia Pengue1, Gonzalo Cesar2, María Gabriela Alvarez1

  • 1Hospital Interzonal General de Agudos Eva Perón, Buenos Aires, Argentina.

Plos One
|June 15, 2019
PubMed

Insights

Chronic Trypanosoma cruzi infection causes hemostatic alterations, impacting platelet and coagulation pathways even before cardiac symptoms appear in Chagas disease patients.

Area of Science:

  • Immunology
  • Cardiovascular Medicine
  • Hematology

Background:

  • Chronic inflammation from Trypanosoma cruzi infection drives immune system activation in Chagas disease.
  • Previous work linked elevated soluble P-selectin to Chagas cardiomyopathy severity.

Purpose of the Study:

  • To investigate biomarkers of platelet and endothelial activation, tissue remodeling, and coagulation in chronic Chagas heart disease stages.
  • To understand hemostatic changes associated with Trypanosoma cruzi infection.

Main Methods:

  • Assessed frequencies of activated platelets (CD41a, CD62P) and adenosine diphosphate-induced platelet activation.
  • Measured serum levels of fibrinogen, endothelin-1, and procollagen I in patients across different clinical stages.
  • Compared findings between infected subjects and uninfected controls.

Main Results:

  • Activated platelet frequencies (CD41a, CD62P) were decreased in T. cruzi-infected patients, inversely correlating with disease severity.
  • Platelet activation by adenosine diphosphate was reduced in infected individuals.
  • Increased serum fibrinogen was observed in many infected subjects.
  • Severe cardiac dysfunction correlated with elevated endothelin-1, while procollagen I levels were normal.

Conclusions:

  • Chronic Trypanosoma cruzi infection induces significant hemostatic alterations.
  • These alterations occur even in patients without overt cardiac symptoms, suggesting early impact on coagulation and platelet function.

Related Concept Videos

Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
3.1K
Nucleosome Remodeling02:54

Nucleosome Remodeling

Nucleosomes are the basic units of chromatin compaction. Each nucleosome consists of the DNA bound tightly around a histone core, which makes the DNA inaccessible to DNA binding proteins such as DNA polymerase and RNA polymerase. Hence, the fundamental problem is to ensure access to DNA when appropriate, despite the compact and protective chromatin structure.
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
10.8K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.3K
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
603
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
261